In a 2025 observational cohort, the Risk of Vestibular Disorders with Semaglutide and Tirzepatide study reported dizziness in 18% of semaglutide users compared with 10% in the control group, indicating a higher-than-baseline incidence and reinforcing the need to monitor for dose- or timing-related patterns
This process may be inhibited in the presence of FOXO4-DRI peptide, allowing p53 to bind with DNA and thereby help the cell cycle to continue to death
(PubMed) Hager K, Marahrens A, Kenklies M, Riederer P, Munch G
Mark Seeley, M.D., PhD, director of Michigan Diabetes Research & Training Center
Keeping a symptom diary can be valuable in identifying potential triggers and patterns
Methods To determine the optimal process for preparing micronized semaglutide powder, pure semaglutide, spray-dried semaglutide and freeze-dried semaglutide were compared